BlueWillow Biologics
BlueWillow Biologics is a clinical‑stage biotechnology company pioneering intranasal vaccine technology. Their NanoVax® platform delivers antigens via an oil‑in‑water emulsion, aiming to transform prevention and treatment of infectious diseases, pandemic preparedness, and food allergies. The company originated from University of Michigan research and now advances human clinical trials of its adjuvant and delivery system.
BlueWillow Biologics is listed with 1 API on the APIs.io network. Tagged areas include Biotechnology, Intranasal Vaccines, Clinical Stage, Nanotechnology, and Health.
BlueWillow Biologics’ developer surface includes product news and 6 more developer resources.
Kin Score
APIs 1
Individual APIs this provider publishes, each with its own machine-readable definition.
BlueWillow Biologics API
API documentation not publicly available; no machine-readable contract discovered.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 4
The organization behind the API
Other 1
Properties that don't map to a standard resource type
Source (apis.yml)
BlueWillow Biologics API — frequently asked questions
Does BlueWillow Biologics have an API?
Yes. APIs.io lists 1 API from BlueWillow Biologics, including BlueWillow Biologics API.
Is the BlueWillow Biologics API ready for AI agents?
BlueWillow Biologics has a Kin Score of 4.1 out of 100 (minimal) and an Agent Readiness score of 0.0 (human-only), scored by API Evangelist on 2026-11-13.
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.